key: cord-0763859-01uwpogl
authors: Godbold, Gene D.; Kappell, Anthony D.; LeSassier, Danielle S.; Treangen, Todd J.; Ternus, Krista L.
title: Categorizing Sequences of Concern by Function To Better Assess Mechanisms of Microbial Pathogenesis
date: 2022-03-22
journal: Infection and immunity
DOI: 10.1128/iai.00334-21
sha: 5b542533280eff4a8aa3cf7238433f46021288bb
doc_id: 763859
cord_uid: 01uwpogl

To identify sequences with a role in microbial pathogenesis, we assessed the adequacy of their annotation by existing controlled vocabularies and sequence databases. Our goal was to regularize descriptions of microbial pathogenesis for improved integration with bioinformatic applications. Here, we review the challenges of annotating sequences for pathogenic activity. We relate the categorization of more than 2,750 sequences of pathogenic microbes through a controlled vocabulary called Functions of Sequences of Concern (FunSoCs). These allow for an ease of description by both humans and machines. We provide a subset of 220 fully annotated sequences in the supplemental material as examples. The use of this compact (∼30 terms), controlled vocabulary has potential benefits for research in microbial genomics, public health, biosecurity, biosurveillance, and the characterization of new and emerging pathogens.

there are few terms for describing parasitism of hosts as practiced at the molecular level by bacterial, fungal, and protozoal pathogens. What terms there are have few annotations associated with them. Often, the only hint in UniProt that a sequence might be involved in deleterious host-affecting activities was through the tag "GO:0009405 (pathogenesis)." As of June 2021, this term was associated with over 277,000 UniProt accession numbers. Interestingly, the GO:0009405 pathogenesis term has been scheduled for obsolescence, with the final notice given in March 2021 (https://github.com/geneontology/go-annotation/issues/3452).

SoCs are not limited to organisms and toxins on the select agent lists (1) . Simply listing the genes of those microbes and toxins would include tens of thousands of innocuous sequences that these parasites share with their close, but nonpathogenic and even nonsymbiotic, relatives (i.e., false positives). This also neglects sequences that cause damage or enable infection from human-disease-causing microbes not deemed serious enough for inclusion on select agent lists (i.e., false negatives). This minireview offers criteria to identify SoCs based on an analysis of more than 2,750 sequences culled from the professional literature for more than 105 bacterial species, 85 viruses, and 25 eukaryotic pathogens. We describe an approach to better characterize these sequences for bioinformatic applications.

Of the hundreds of thousands of species of bacteria, fungi, protozoa, worms, and viruses on the planet, only a small percentage have been documented to cause disease in the primate Homo sapiens. It was estimated in 2007 that ;1,400 microbes and parasites can produce disease in humans. Of these, 541 were bacterial, 325 fungal, 285 helminthic, 189 viral, and 57 protozoal (4) . Further studies indicated that ;600 fungi can cause disease in humans (5) , and well over 200 RNA viruses can infect humans (6) , so the total number of human-disease-causing entities is greater than 1,750 and is probably closer to 2,000.

Parasites are distinguished from closely related symbionts by their expression of specific molecules that, when deployed appropriately, can cause a loss of homeostasis (i.e., disease), in a susceptible host. Particular environmental conditions can dispose a host toward greater susceptibility and a parasite toward greater disease-generating ability (7) . While many sequences from human-disease-causing microbes have been examined empirically, "the majority. . .from the microorganisms responsible for the world's most prevalent diseases remain poorly defined and uncharacterized" (8) .

Practitioners of the biological subspecialty of microbial pathogenesis, a hybrid of cellular biology, molecular biology, and microbiology, investigate the sequences by which microbes exploit host organisms. Perhaps the earliest exploration occurred 50 years ago in swine by Williams Smith and Margaret Linggood. They showed that nonpathogenic Escherichia coli could become an enterotoxigenic pathogen with the introduction of plasmids encoding F4 fimbriae and enterotoxin (9) .

Testing a mechanism that directly contributes to pathogenesis makes for the most satisfying investigations. In 2007, experiments were conducted using mice of the same genetic background, while the Citrobacter rodentium bacteria used to infect the mice were varied in which set of up to seven effectors they expressed. The authors showed how the set of sequences expressed rendered the pathogen capable, less capable, or incapable of transmission to a new host and more or less proficient at causing lethal damage (10) . Unfortunately, there are more than a few papers declaring a gene product a "virulence factor" after experiments show a "decrease in virulence" following deletion of the gene, though no mechanism can be inferred. In the absence of adequate controls, the gene product in question may simply be necessary to the normal functioning of the organism without necessarily affecting the host.

(i) When "virulence factors" are not sequences of concern. The "virulence factor" appellation is rife in the literature. "Factor" covers carbohydrates, lipids, proteins, and combinations thereof, as well as small RNAs. Encoded virulence factors are prima facie candidates for SoCs. However, molecules called virulence factors are not always a threat to a host. Bacterial siderophores are called virulence factors, but most are scavenging molecules without which the bacterium would perish in any environment where metal cofactors are rare. It makes more sense to designate these "virulence lifestyle" sequences (11) , or perhaps "proliferative factors." The less-than-discriminating use of "virulence factor" makes it difficult for investigators to discern what sequences actually harm a host (12) . Not all virulence factors are SoCs.

Researcher designations of virulence factors are critical for curators to recognize them, but the less-than-thoughtful use of the nomenclature can create problems for bioinformaticians. An analysis of 2,000 purported virulence factors from over 50 bacterial pathogens found that just 620 were specific to pathogens while 1,368 were common to both pathogens and nonpathogens. The 620 pathogen-specific virulence factors were more likely to reside in pathogenicity islands and be secreted via a secretion system (13) . In contrast, the 1,368 "common" virulence factors are probably not SoCs. If put into a reference database of "virulence factors," they would be false positives. An adequate system for categorizing SoCs should recognize these differences.

(ii) Existing virulence factor data sets and the importance of manual curation of function. Many databases of virulence factors do not curate their sequences according to an established rubric that allows for the extraction of function. The Virulence Factor Database (VFDB) is limited to bacteria pathogenic for humans. The developers eschew manual curation (14) . The data set associated with VFDB includes ;3,400 sequences from ;21 bacterial species. No justification is given for the presence of constituent sequences. No curations keyed to individual sequences are provided. The Pathogen-Host Interaction Database (PHI-Base) captures the genetics of pathogenhost interactions from the primary literature along with some functional details, but it principally notes changes in virulence that accompany genetic variants. The effect that these parasite sequences have on the host are of secondary importance (15) . The same is true of the Victors database (16) . A comparison of bacterium-related databases suggests that functional annotation of SoCs is not a significant concern (17). We think that manual curation is required to adequately annotate the consequences that SoCs have on host processes and enable further advances in computational biology.

There is a chicken-and-egg aspect to identifying SoCs. One must have some idea of what microbial features might be threatening to know what to examine, but it is not until "enough" sequences are perused that the important aspects can be recognized categorically. By reviewing the literature, we discovered sequences that appear important to pathogenesis for parasites of humans, as well as those of animals and plants necessary to human well-being. We have documented over 2,750 of these, which we hope is a fair sample to develop a conceptualization for understanding biothreats. Assessing sequences of concern for their danger in a bioengineering, gain-of-function (GoF) scenario required us to consider two parameters: (i) the effect on the host, including which host processes are manipulated, and (ii) how directly the sequence exerts its effects. For this minireview, we limit ourselves to reviewing functions of SoCs (FunSoCs) from microbes targeting mammals. The FunSoCs are summarized in Fig. 1 and discussed below. Included as supplemental material is a table of short definitions for the FunSoCs (Data Set S1) and a spreadsheet (Data Set S2) with 220 sequence types from 60 pathogenic species (bacterial, fungal, protozoal, viral) annotated with UniProt accession numbers, FunSoCs, and PubMed identifiers to illustrate our curation.

(i) What is the effect of the SoC on the host? (a) Host damage as the sine qua non of pathogenicity. It is generally true that lethal infections are deadly because one or more organs become disabled from cumulative damage. Ascertaining the proximal cause of damage can be problematic. Host damage can be the direct result of the parasite's action on the host, the host's reaction to the parasite, or both. While infectious disease theorists of the 20th century once credited the pathogen with unique disease-causing ability, this is no longer tenable (18) (19) (20) .

Damage is the hallmark of pathogenicity (21) . Since this is the case, "toxins" might be said to occupy the preeminent place among virulence factors since they are among the most damaging of molecules deployed by pathogens. In bacteria, toxins are distinguished from damaging effectors in that the former are capable of mediating their own attachment and invasion into a cell, while effectors must be secreted (22) .

The term "toxin" is notably nonspecific and amounts to little more than a verbal tag that a molecule is inimical to the life of one or more taxa. But the taxa susceptible to the toxin need to be understood. Alpha-amanitin, bicuculline, carbon monoxide, chlorine gas, ciguatoxin, cyanide, MARTX from Vibrios, ricin, and sarin have disparate modes of action and are all deadly to mammals if administered appropriately. In contrast, the toxins of toxin/antitoxin (TA) systems are not hazardous for mammals; however, they might be administered (23) . Of course, toxins do not exhaust the range of damaging biological sequences. The following paragraphs attempt to categorize host damage caused by SoCs. (94) . This class of effectors may require splitting into microbially induced versus microbially provoked host inflammation.

(b) Immune subversion as an essential condition for pathogenicity. Stanley Falkow observed that the avoidance of host defense mechanisms was a feature of diseasecausing bacteria (95) . Sequences that subvert innate immune pathways are also found in fungal and protozoan parasites and are a universal feature of viruses. Immune systems embody the "wisdom" of hundreds of millions of years of adaptation over which they have had to detect, deflect, and defeat micro-and macroparasites (96) (97) (98) . More than 6% of all human genes have a role in immunity (99) . Immune systems impose layers of molecular and cellular obstacles to thwart invaders that breach epidermal barriers. Parasites survive these host stratagems by employing molecules that mask their presence, mimic and/or misdirect host responses, or simply eliminate immune effectors. Of the SoCs that we documented, ;60% of the viral sequences and ;20% of the bacterial and eukaryotic sequences subvert host immune responses.

Deficits in immune detectors and effectors of a host can render commensal symbionts pathogenic and infections with "nuisance" organisms lethal. Subtle changes in the sequence of a single host immune effector molecule can mean the difference between life and death during challenge with a parasite (100) . The study of human immune deficiencies shows the critical importance of these components of innate immunity for defense against the specific, usually narrow, set of parasites against which they defend (101-103). Many infections run their nonlethal course according to the life cycle of the parasite when facing an average host immune response. These are sometimes called "self-limiting" infections, but a defect or deficit in a host immune component can abolish the limitation and produce a life-threatening disease.

Of the ;2,000 parasites that can cause disease in humans, the majority are opportunistic: limited to infecting immunocompromised persons (4, 5) . The "opportunity" occurs when a proto-parasite encounters an individual whose immune defenses are diminished from (i) loss of barrier function, (ii) congenital immune defects, (iii) infection with HIV, (iv) immune-suppressing pharmacotherapy, or (v) other disease states that alter the homeostasis of the host. These render the host susceptible to microbial parasites that could not successfully establish themselves otherwise. SoCs mediating immune subversion essentially make a host susceptible in the absence of a compromised immune system. Some immune-evading SoCs from Streptococcus are shown in Fig. 2 (294, 295) , and secreted phospholipase A2 (Sla) (296) . Neutrophil extracellular traps (NETs) are countered by the Sda1 and SpnA nucleases (264, 265) . Antimicrobial peptides are inactivated by the secreted streptococcal inhibitor of complement (Sic) and SpeB proteases (200, 201) . M-like proteins bind host factor H and plasminogen/plasmin, which inactivate host complement components to protect the bacterium (297) . Sic protects streptococci from phagocytosis by neutrophils, resists the host complement membrane attack complex (MAC) (70), and counters the antibacterial actions of the host secretory leukocyte proteinase inhibitor (SLPI) (200, 201) . Host antibodies are destroyed by membrane-associated ZmpC (226) and the secreted IdeS proteases (222) and inactivated by sugar-cleaving EndoS (223) . The group B Streptococcus C5a peptidase ScpB is a serine protease and surface invasin (298) that reduces the neutrophil response and bacterial clearance by cutting the chemoattractant C5a (299) . The streptococcal complement protector ScpA helps the bacterium resist phagocytosis (183) and also inactivates C5a (300) . SpyCEP eliminates the neutrophil chemoattractant IL-8 (230) and other chemokines (225) . Note that this figure depicts SoCs found in both group A and group B streptococci for illustrative purposes, but they would not naturally occur together. (111) (191) , or inactivated indirectly, as by CipA from Acinetobacter baumannii, which recruits host plasminogen to the bacterial surface (192) . BclA of B. anthracis mediates serum resistance by recruiting factor H, a host complement control protein, to the bacterial surface (193) . 4. Resistance to antimicrobial peptides. Host antimicrobial proteins are cationic peptides that interact with the negatively charged bacterial membrane. They can be destroyed by bacterial proteases, including OmpA from Klebsiella (194) , ClpX from B. anthracis (195) , CPAF from Chlamydia (196) , staphylokinase from S. aureus (179) , SepA from Staphylococcus epidermidis (197) , DRS (198) , SspA, SspB (199) , SpeB, and Sic from Streptococcus (200, 201) , and OmpU from V. cholerae (202 (c) Adherence to the host cell. To affect the host, symbionts need to either secrete toxins that act while the microbe is at a distance from the host cell or contact host cells or tissues directly. This requires specific adhesin molecules that anchor them, however durably, to the host. Toxins also require adhesins to recognize target cells. Adherence can be to specific host protein receptors, to carbohydrate moieties of glycoproteins or glycolipids, to membrane cholesterol, and/or to components of the host extracellular matrix. Such proteins are abundant, and host attachment is often just one of their functions (272, 273) .

(d) Dissemination in the host. Dissemination factors enable the breaching of host barriers. A breach can happen by proteolytic digestion of tissues or the release of junctional adhesins to allow parasite passage. SoCs that degrade tissue can also be dissemination factors. Examples include ExoS and ExoU from P. aeruginosa (274) , InhA from B. anthracis (39, 275) , and staphylococcal exfoliative toxins (50, 55, 276) .

(e) Host cell invasion. A microsymbiont can "enter" a host cell easily when the host cell is a professional phagocyte, but this happens under conditions unfavorable for symbiont survival. Invasins mediate microbial entry into a range of host cells, including nonphagocytic ones, in ways that allow the parasite a greater probability of reproductive success. Bacterial toxins also possess invasive subunits that enable their entry into host cells; this distinguishes them from effectors, which require a secretion system (22) .

(f) Movement in host cell. Movement within a host cell allows a parasite to circumvent host barriers and avoid programmed defenses. Some intracellular bacteria, as well as vaccinia virions, hijack host actin polymerization to propel themselves into adjacent cells. They thus avoid exposure to the hazards of the extracellular milieu (277) .

(g) Niche creation in host cells. Some cellular microbial symbionts manipulate host cell processes to create intracellular niches, where they are protected from host destruction and in which they replicate. This has been investigated most thoroughly in Brucella, Chlamydia, Coxiella, Ehrlichia, Legionella, Listeria, Mycobacteria, and Salmonella. SoCs from these bacteria are generally secreted and subvert the normal endosomal and cytoskeletal dynamics of the host cell. Sorting out the mechanisms for these effectors-there are hundreds just in Legionella-is exceedingly complicated, as many are redundant (278) .

(ii) How directly does the sequence exert its effect? When considering the ease with which the disease-causing capacity of a pathogen might be enhanced by sequence addition/gain-of-function (GoF), it is important to consider how directly the SoC acts on the host. SoCs that act independently without the need for extra (i.e., secondary or tertiary) sequences would affect virulence more parsimoniously. There are at least four levels of SoC involvement in pathogenesis.

1. Type 1 sequences that directly interact with host molecules to contribute to disease are the most concerning. The SoCs described above (i.e., damage, immune evasion, adherence, invasion, movement, dissemination, niche creation) act directly to produce a specific deleterious effect. 2. Type 2 sequences make or modify molecules that affect the host. These include toxin synthases, enzymes that make capsules rendering bacteria resistant to phagocytosis, and "passive immune evasion" enzymes which alter microbial molecules to protect the possessor from host recognition and/or immune effectors. Examples of the latter include AlmG, a peripheral membrane aminoacyl transferase from V. cholerae that modifies lipopolysaccharide to resist host cationic antimicrobial peptides (279) , and Cbu0678 from C. burnetii, which changes the O antigen of lipopolysaccharide (LPS) to decrease immune recognition (280). 3. Type 3 sequences are secretion system components that transport directly acting SoCs to the correct location for function. These include chaperones for the effector proteins. 4. Type 4 sequences are transcription factors regulating the expression of sequences that produce effects directly. While they can be very important for the virulence of a microbe and greatly influence how pathogenic a specific microorganism can be, they might be replaced in a GoF scenario by similar factors.

(iii) What host cellular process is affected? We found it helpful to annotate SoCs with the host processes that they modulate, as these can often be discerned before the biochemical mechanisms are discovered. No fewer than nine aspects of eukaryotic host cell biology are targeted by parasite proteins for manipulation: (1) transcription, (2) translation, (3) the cell cycle, (4) apoptosis, (5) ubiquitination, (6) small GTPase dynamics, (7) cytoskeleton dynamics, (8) endomembrane, dynamics, and (9) autophagy/xenophagy. Viruses tend to manipulate the first five processes, while bacteria, particularly intracellular parasites, affect the final six, with overlap at apoptosis and ubiquitination.

Gauging the risks of an emerging pathogen strain or one created through microbial engineering (accidental or otherwise) requires a good comprehension of the pathogenic possibilities of SoCs from natural parasites of humans and livestock. An assessment of existing controlled vocabularies revealed a gap for sequences from nonviral parasites. We documented the role played in disease of over 2,750 parasite proteins from thousands of papers. These were annotated with the FunSoC schema, which categorizes their host-affecting features. The 220 sequences mentioned in this text are provided with full annotations in Data Set S2 in the supplemental material, with definitions provided in Data Set S1.

FunSoCs are tidy enough for human comprehension. For a given SoC, they provide a quick assessment for ;30 host-affecting functions. However, they are insufficiently granular for capturing the molecular details necessary for a comprehensive appreciation of function. We think that these details are better understood with a new adjunct to GO, Pathogen Gene Ontology (PathGO). This resource is being developed by a group at the Johns Hopkins University Applied Physics Laboratory and consists of ;180 terms (https://github.com/jhuapl-bio/pathogenesis-gene-ontology). These are being rooted in biological process and molecular function terms of the Gene Ontology resource (281, 282) . We have been suggesting terms and contributing annotations during development. Data Set S2 features a preview of PathGO terms in column F, along with the relevant PubMed ID accession numbers as citations. PathGO will be described in a future publication.

(i) The utility of gain-of-function experiments in microbial pathogenesis. Sometimes eliminating a bacterial sequence suspected of involvement in pathogenicity has no effect. Legionella pneumophila exhibits so much functional redundancy in its effectors that the loss of one or two sequences of a certain type may not affect the phenotype (283) . Investigators of bacterial adhesion face a similar situation when the suspected adhesin originates in a microbe with multiple ways of associating with a target cell. Researchers circumvent this by studying the adhesin in the background of a specially selected "nonadherent" bacterium (284) (285) (286) (287) (288) (289) . Experiments in which a sequence "adds" virulence to commensals or avirulent microbes is more interpretable than attempts to ascertain virulence by subtraction from a pathogenic background. The former involves a GoF for the avirulent microbe.

Only a few efforts to make bad bugs worse intentionally have been described (290) . However, there are hundreds of publications relating the expression of one or more sequences from an infectious parasite in a heterologous organism. Two dozen of these are noted in column E of Data Set S2. Altered organisms typically display a new property consistent with the suspected pathogenic function of the sequence in the original organism. These GoF experiments are illuminating but can also be problematic (291, 292) . The role that a sequence plays in the pathogenicity of a microbe can depend on other proteins and/or the timing of its expression. Simply expressing the sequence in another microbe, even a similar one, is no guarantee that it will perform similarly. The question can be settled only empirically within the limits of the model. The most dramatic example of a GoF experiment with biothreat implications is the notorious mouse interleukin-4 (IL-4) expression in Ectromelia virus that was astoundingly lethal in even vaccinated animals (293) . An intriguing bacterial example involves the secreted protease SpyCEP of group A Streptococcus. When the nontoxic SpyCEP was expressed in the nonpathogenic bacterium Lactococcus lactis, it rendered the cheese-making firmicute capable of infection in a mouse leg wound model. The SpyCEP protease degrades the chemokine interleukin-8, which host neutrophils use to coordinate their defense, "sniffing out" bacteria within infected tissues. Interruption of this coordination produced a systemic disease that had lethal consequences for the host within 24 h of inoculation (230) .

(ii) Recognized criteria for sequences of concern improve biosecurity. For those worried about either the accidental engineering of pathogens via synthetic biology or the production of bioweapons with enhanced efficacy, a concerning sequence is one that, when transferred to a different microbe, increases the ability of that microbe to damage a susceptible host, increasing the pathological consequences of infection. But, as the cases of SpyCEP and murine IL-4 demonstrate, the disease-causing properties of microbes have interesting dependencies that cannot be understood in the absence of experiments. We think that the criterion of enhanced pathogenicity upon expression in a heterologous nonpathogen is a good starting place for identifying SoCs, but most will not be discovered through such GoF experiments. Our annotation project has demonstrated that there are thousands of microbial sequences that can reasonably be assumed to enhance the pathogenic ability of a heterologous microbe if transferred. In such cases, the disease-causing properties of these sequences are described in the context of the original pathogenic organism and not in a heterologous, nonpathogenic microbe. We assume that these sequences may retain their properties if transferred to a similar microbe. At the very least, it does not seem responsible to assume that they would be innocuous. Documenting these sequences enables them to be recognized via bioinformatics and thus improves biosecurity for those involved in the manufacture of synthetic nucleic acids (2) .

Toxins and microbial effectors that damage the human host are of greatest concern. Among these, SoCs that provoke organ failure have the most severe consequences. Next in importance are sequences that subvert host immunity. Noting the host cellular process(es) with which a SoC interacts and how directly it affects host molecules allows a better understanding of its role in microbial pathogenesis. Formalizing these criteria improve recognition of SoCs from the literature, provide the means for distinguishing them by function, and permit the reporting of these functions in bioinformatic applications. We think that the FunSoC vocabulary and data sets annotated with it can be a resource for computational epidemiology, microbial genomics and forensics, DNA synthesis screening, human disease modeling, and biosecurity assessment.

Supplemental material is available online only. 

Sequence-based classification of select agents: a brighter line

Next steps for access to safe, secure DNA synthesis

The UniProtKB/Swiss-Prot Tox-Prot program: a central hub of integrated venom protein data

Ecological origins of novel human pathogens

Tackling human fungal infections

Epidemiological characteristics of human-infective RNA viruses

What is a pathogen? Toward a process view of host-parasite interactions

Cryptosporidium pathogenicity and virulence

Observations on the pathogenic properties of the K88, Hly and Ent plasmids of Escherichia coli with particular reference to porcine diarrhoea

Virulence is positively selected by transmission success between mammalian hosts

Bacterial virulence: can we draw the line?

Critical Streptococcus suis virulence factors: are they all really critical?

Common and pathogen-specific virulence factors are different in function and structure

VFDB 2019: a comparative pathogenomic platform with an interactive web interface

PHI-base: the pathogen-host interactions database

Victors: a web-based knowledge base of virulence factors in human and animal pathogens

Contents, construction methods, data resources, and functions comparative analysis of bacteria databases

The damage-response framework of microbial pathogenesis

Microbiology: ditch the term pathogen

What is infectiveness and how is it involved in infection and immunity?

The damage-response framework as a tool for the physician-scientist to understand the pathogenesis of infectious diseases

Common themes in the design and function of bacterial effectors

Post-segregational killing and phage inhibition are not mediated by cell death through toxin/antitoxin systems

The pyrin inflammasome in health and disease

Molecular Koch's postulates applied to microbial pathogenicity

Origin and evolution of the adaptive immune system: genetic events and selective pressures

Evolution of innate and adaptive immune systems in jawless vertebrates

Evolutionary genetics of insect innate immunity

Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data

A natural genetic variant of granzyme B confers lethality to a common viral infection

Human genetic basis of interindividual variability in the course of infection

Severe infectious diseases of childhood as monogenic inborn errors of immunity

Inborn errors of immunity underlying fungal diseases in otherwise healthy individuals

Metalloprotease type III effectors that specifically cleave JNK and NF-k B

Bacterial effector NleL promotes enterohemorrhagic E. coliinduced attaching and effacing lesions by ubiquitylating and inactivating JNK

SptP, a Salmonella typhimurium type IIIsecreted protein, inhibits the mitogen-activated protein kinase pathway by inhibiting Raf activation

The role of host cell death in Salmonella infections

The phosphothreonine lyase activity of a bacterial type III effector family

Salmonella type III effector SpvC, a phosphothreonine lyase, contributes to reduction in inflammatory response during intestinal phase of infection

An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses

Functional and phylogenetic characterization of Vaginolysin, the human-specific cytolysin from Gardnerella vaginalis

Acetylation of MEK2 and I kappa B kinase (IKK) activation loop residues by YopJ inhibits signaling

NFkB inhibitors: strategies from poxviruses

Unraveling the mechanism of action of a new type III secretion system effector AexU from Aeromonas hydrophila

Bordetella evades the host immune system by inducing IL-10 through a type III effector, BopN

Modulation of NF-k B signalling by microbial pathogens

Suppression of host innate immune response by Burkholderia pseudomallei through the virulence factor TssM

Salmonella effector AvrA regulation of colonic epithelial cell inflammation by deubiquitination

A family of Salmonella type III secretion effector proteins selectively targets the NF-k B signaling pathway to preserve host homeostasis

The Listeria monocytogenes InlC protein interferes with innate immune responses by targeting the Ik B kinase subunit IKKa

Shigella flexneri suppresses NF-k B activation by inhibiting linear ubiquitin chain ligation

Manipulation of kinase signaling by bacterial pathogens

Structural mechanism for guanylate-binding proteins (GBPs) targeting by the Shigella E3 ligase IpaH9

The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes

Structural basis for the inhibition of host protein ubiquitination by Shigella effector kinase OspG

NleC, a type III secretion protease, compromises NF-k B activation by targeting p65/RelA

Metalloprotease NleC suppresses host NF-k B/inflammatory responses by cleaving p65 and interfering with the p65/RPS3 interaction

NleB/SseK effectors from Citrobacter rodentium, Escherichia coli, and Salmonella enterica display distinct differences in host substrate specificity

Functional differences and interactions between the Escherichia coli type III secretion system effectors NleH1 and NleH2

Hsp90 interacts with the bacterial effector NleH1

Legionella pneumophila inhibits immune signalling via MavC-mediated transglutaminaseinduced ubiquitination of UBE2N

Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with Toll-like receptor signaling

Pathogen blocks host death receptor signalling by arginine GlcNAcylation of death domains

Citrobacter rodentium NleB protein inhibits tumor necrosis factor (TNF) receptor-associated factor 3 (TRAF3) ubiquitination to reduce host type I interferon production

To kill or be killed: viral evasion of apoptosis

The type III secretion effector NleE inhibits NF-kappaB activation

Enteropathogenic Escherichia coli Tir recruits cellular SHP-2 through ITIM motifs to suppress host immune response

Enterohemorrhagic Escherichia coli Tir inhibits TAK1 activation and mediates immune evasion

Salmonella effectors SseK1 and SseK3 target death domain proteins in the TNF and TRAIL signaling pathways

The Shigella flexneri effector OspI deamidates UBC13 to dampen the inflammatory response

Toxoplasma gondii GRA7-induced TRAF6 activation contributes to host protective immunity

Toxoplasma GRA15 activates the NF-k B pathway through interactions with TNF receptor-associated factors

Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKK« -mediated IRF activation

Viral immune modulators perturb the human molecular network by common and unique strategies

YopJ targets TRAF proteins to inhibit TLR-mediated NF-kappaB, MAPK and IRF3 signal transduction

Phosphatidylinositol-specific phospholipase C of Bacillus anthracis down-modulates the immune response

Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection

EBV lyticphase protein BGLF5 contributes to TLR9 downregulation during productive infection

The Mycobacterium tuberculosis protein pair PE9 (Rv1088)-PE10 (Rv1089) forms heterodimers and induces macrophage apoptosis through Toll-like receptor 4

Staphylococcal superantigen-like protein 3 binds to the Toll-like receptor 2 extracellular domain and inhibits cytokine production induced by Staphylococcus aureus, cell wall component, or lipopeptides in murine macrophages

Evasion of Toll-like receptor 2 activation by staphylococcal superantigen-like protein 3

Chikungunya virus nonstructural protein 2 inhibits type I/II interferonstimulated JAK-STAT signaling

Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane

RIG-I is cleaved during picornavirus infection

Poxvirus immunomodulatory strategies: current perspectives

Biophysical characterization of the complex between doublestranded RNA and the N-terminal domain of the NS1 protein from influenza A virus: evidence for a novel RNA-binding mode

Marburg virus VP35 can both fully coat the backbone and cap the ends of dsRNA for interferon antagonism

DNA tumor virus oncogenes antagonize the cGAS-STING DNA-sensing pathway

Further characterization of a type III secretion system (T3SS) and of a new effector protein from a clinical isolate of Aeromonas hydrophila-part I

Bartonella adhesin a mediates a proangiogenic host cell response

Macrophage cytotoxicity produced by adenylate cyclase toxin from Bordetella pertussis: more than just making cyclic

BteA secreted from the Bordetella bronchiseptica type III secretion system induces necrosis through an actin cytoskeleton signaling pathway and inhibits phagocytosis by macrophages

Borrelia burgdorferi inhibits human neutrophil functions

Candida albicans factor H binding molecule Hgt1p-a low glucose-induced transmembrane protein is trafficked to the cell wall and impairs phagocytosis and killing by human neutrophils

Identification of App1 as a regulator of phagocytosis and virulence of Cryptococcus neoformans

App1: an antiphagocytic protein that binds to complement receptors 3 and 2

Immune evasion of Enterococcus faecalis by an extracellular gelatinase that cleaves C3 and iC3b

EspJ of enteropathogenic and enterohaemorrhagic Escherichia coli inhibits opsono-phagocytosis

Serine protease autotransporters from Shigella flexneri and pathogenic Escherichia coli target a broad range of leukocyte glycoproteins

Aspergillus fumigatus LaeA-mediated phagocytosis is associated with a decreased hydrophobin layer

Bacterial pathogens commandeer Rab GTPases to establish intracellular niches

The ADP ribosyltransferase domain of Pseudomonas aeruginosa ExoT contributes to its biological activities

Pseudomonas aeruginosa ExoS and ExoT

Staphylococcus aureus metalloprotease aureolysin cleaves complement C3 to mediate immune evasion

Early expression of SCIN and CHIPS drives instant immune evasion by Staphylococcus aureus

Inhibition of complement activation by a secreted Staphylococcus aureus protein

A structural basis for complement inhibition by Staphylococcus aureus

The immune evasion protein Sbi of Staphylococcus aureus occurs both extracellularly and anchored to the cell envelope by binding lipoteichoic acid

Staphylococcal innate immune evasion

Threedimensional solution structure of the B domain of staphylococcal protein A: comparisons of the solution and crystal structures

BibA: a novel immunogenic bacterial adhesin contributing to group B Streptococcus survival in human blood

Coiled-coil irregularities and instabilities in group A Streptococcus M1 are required for virulence

Multifunctional glyceraldehyde-3-phosphate dehydrogenase of Streptococcus pyogenes is essential for evasion from neutrophils

Vibrio vulnificus MARTX cytotoxin causes inactivation of phagocytosis-related signaling molecules in macrophages

Vibrio VopQ induces PI3-kinaseindependent autophagy and antagonizes phagocytosis

The pH 6 antigen is an antiphagocytic factor produced by Yersinia pestis independent of Yersinia outer proteins and capsule antigen

ROS-inhibitory activity of YopE is required for full virulence of Yersinia in mice

The Yersinia Ysc-Yop "type III" weaponry

Biochemical characterization of the Yersinia YopT protease: cleavage site and recognition elements in Rho GTPases

Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis

Acquisition of C1 inhibitor by Bordetella pertussis virulence associated gene 8 results in C2 and C4 consumption away from the bacterial surface

CipA of Acinetobacter baumannii is a novel plasminogen binding and complement inhibitory protein

Bacillus anthracis spore surface protein BclA mediates complement factor H binding to spores and promotes spore persistence

Klebsiella pneumoniae OmpA confers resistance to antimicrobial peptides

ClpX contributes to innate defense peptide resistance and virulence phenotypes of Bacillus anthracis

Chlamydia-secreted protease CPAF degrades host antimicrobial peptides

Staphylococcus epidermidis strategies to avoid killing by human neutrophils

Streptococcal DRS (distantly related to SIC) and SIC inhibit antimicrobial peptides, components of mucosal innate immunity: a comparison of their activities

Role of surface proteins SspA and SspB of Streptococcus gordonii in innate immunity

The interaction of streptococcal inhibitor of complement (SIC) and its proteolytic fragments with the human beta defensins

Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

Crystal structure of the outer membrane protein OmpU from Vibrio cholerae at 2.2 Å resolution

Four superoxide dismutases contribute to Bacillus anthracis virulence and provide spores with redundant protection from oxidative stress

Cloning, expression, and characterization of a Coxiella burnetii Cu/Zn Superoxide dismutase

Type VI secretion system contributes to enterohemorrhagic Escherichia coli virulence by secreting catalase against host reactive oxygen species (ROS)

Identification of Francisella tularensis live vaccine strain CuZn superoxide dismutase as critical for resistance to extracellularly generated reactive oxygen species

Characterization of a Staphylococcus aureus surface virulence factor that promotes resistance to oxidative killing and infectious endocarditis

Ehrlichia chaffeensis and its invasin EtpE block reactive oxygen species generation by macrophages in a DNase X-dependent manner

Mycobacterium tuberculosis nucleoside diphosphate kinase inactivates small GTPases leading to evasion of innate immunity

Mycobacterium tuberculosis PPE32 promotes cytokines production and host cell apoptosis through caspase cascade accompanying with enhanced ER stress response

The Mycobacterium tuberculosis PE proteins Rv0285 and Rv1386 modulate innate immunity and mediate bacillary survival in macrophages

Identification of the Mycobacterium tuberculosis protein PE-PGRS62 as a novel effector that functions to block phagosome maturation and inhibit iNOS expression

The Salmonella effector SopB prevents ROS-induced apoptosis of epithelial cells by retarding TRAF6 recruitment to mitochondria

T3SS effector VopL inhibits the host ROS response, promoting the intracellular survival of Vibrio parahaemolyticus

Identifying Yersinia YopH-targeted signal transduction pathways that impair neutrophil responses during in vivo murine infection

Serendipitous discovery of an immunoglobulin-binding autotransporter in Bordetella species

Microbial IgA protease removes IgA immune complexes from mouse glomeruli in vivo: potential therapy for IgA nephropathy

Histophilus somni surface proteins

Histophilus somni survives in bovine macrophages by interfering with phagosomelysosome fusion but requires IbpA for optimal serum resistance

Structural basis for inhibition of complement C5 by the SSL7 protein from Staphylococcus aureus

Anti-opsonic properties of staphylokinase

IdeS and SpeB: immunoglobulin-degrading cysteine proteinases of Streptococcus pyogenes

Crystal structure of Streptococcus pyogenes EndoS, an immunomodulatory endoglycosidase specific for human IgG antibodies

Identification and characterization of a novel secreted immunoglobulin binding protein from group A Streptococcus

Secreted extracellular virulence factors

Pneumococcal zinc metalloproteinase ZmpC cleaves human matrix metalloproteinase 9 and is a virulence factor in experimental pneumonia

The invasin D protein from Yersinia pseudotuberculosis selectively binds the Fab region of host antibodies and affects colonization of the intestine

Staphylococcal SSL5 inhibits leukocyte activation by chemokines and anaphylatoxins

Pseudomonas aeruginosa protease IV exacerbates pneumococcal pneumonia and systemic disease

Chemokine-cleaving Streptococcus pyogenes protease SpyCEP is necessary and sufficient for bacterial dissemination within soft tissues and the respiratory tract

Multipronged attenuation of macrophage-colony stimulating factor signaling by Epstein-Barr virus BARF1

An Epstein-Barr virus encoded inhibitor of colony stimulating factor-1 signaling is an important determinant for acute and persistent EBV infection

Viral mechanisms of immune evasion

Variola virus immune evasion proteins

A chemokine-binding domain in the tumor necrosis factor receptor from variola (smallpox) virus

Properties of the recombinant TNF-binding proteins from variola, monkeypox, and cowpox viruses are different

Recombinant TNF-binding protein from variola virus as a novel potential TNF antagonist

Structure of CrmE, a virus-encoded tumour necrosis factor receptor

Evasion of innate immunity by vaccinia virus

Structure and mechanism of IFN-gamma antagonism by an orthopoxvirus IFN-gamma-binding protein

Glycosaminoglycans mediate retention of the poxvirus type I interferon binding protein at the cell surface to locally block interferon antiviral responses

The interferon system and vaccinia virus evasion mechanisms

Poxviruses and immune evasion

Mycobacterium tuberculosis type VII secreted effector EsxH targets host ESCRT to impair trafficking

The great escape: viral strategies to counter BST-2/tetherin

Varicella zoster virus immune evasion strategies

The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation

Distinct roles of extracellular domains in the Epstein-Barr virus-encoded BILF1 receptor for signaling and major histocompatibility complex class I downregulation

Viral evasion of T cell immunity: ancient mechanisms offering new applications

Epstein-Barr virus isolates retain their capacity to evade T cell immunity through BNLF2a despite extensive sequence variation

The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination

Epstein-Barr virus evades CD41 T cell responses in lytic cycle through BZLF1-mediated downregulation of CD74 and the cooperation of vBcl-2

Adenovirus E1A interacts directly with, and regulates the level of expression of, the immunoproteasome component MECL1

MHC class I antigen presentation: learning from viral evasion strategies

Immune evasion by Mycobacterium tuberculosis: living with the enemy

TLR2 and its co-receptors determine responses of macrophages and dendritic cells to lipoproteins of Mycobacterium tuberculosis

Mycobacterium tuberculosis LprA is a lipoprotein agonist of TLR2 that regulates innate immunity and APC function

Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing

PPE38 protein of Mycobacterium tuberculosis inhibits macrophage MHC class I expression and dampens CD81 T cell responses

The Salmonella effector SteD mediates MARCH8-dependent ubiquitination of MHC II molecules and inhibits T cell activation

Shigella effector IpaH4.5 targets 19S regulatory particle subunit RPN13 in the 26S proteasome to dampen cytotoxic T lymphocyte activation

A thermonuclease of Neisseria gonorrhoeae enhances bacterial escape from killing by neutrophil extracellular traps

An endonuclease allows Streptococcus pneumoniae to escape from neutrophil extracellular traps

Group A Streptococcus secreted esterase hydrolyzes platelet-activating factor to impede neutrophil recruitment and facilitate innate immune evasion

Characterization of a virulence-associated and cell-wall-located DNase of Streptococcus pyogenes

Role of Hcp, a type 6 secretion system effector, of Aeromonas hydrophila in modulating activation of host immune cells

Legionella effector AnkX interacts with host nuclear protein PLEKHN1

Multiple Legionella pneumophila effector virulence phenotypes revealed through high-throughput analysis of targeted mutant libraries

Potentiation of cytokine-mediated restriction of Legionella intracellular replication by a Dot/ Icm-translocated effector

ESX secretion-associated protein C from Mycobacterium tuberculosis induces macrophage activation through the Toll-like receptor-4/mitogen-activated protein kinase signaling pathway

The Salmonella type III effector SspH2 specifically exploits the NLR co-chaperone activity of SGT1 to subvert immunity

Microbial adhesins to gastrointestinal mucus

Bacterial adhesins, the pathogenic weapons to trick host defense arsenal

Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung

Bacillus anthracis protease InhA regulates BslA-mediated adhesion in human endothelial cells

Cloning of swine desmoglein 1 and its direct proteolysis by Staphylococcus hyicus exfoliative toxins isolated from pigs with exudative epidermitis

Actin-based motility of intracellular pathogens

Manipulation of host cell organelles by intracellular pathogens

AlmG, responsible for polymyxin resistance in pandemic Vibrio cholerae, is a glycyltransferase distantly related to lipid A late acyltransferases

Genetic mechanisms of Coxiella burnetii lipopolysaccharide phase variation

Gene Ontology: tool for the unification of biology. The Gene Ontology Consortium

The Gene Ontology resource: enriching a GOld mine

The toolbox for uncovering the functions of Legionella Dot/Icm type IVb secretion system effectors: current state and future directions

Neisseria meningitidis App, a new adhesin with autocatalytic serine protease activity

The fibrinogen receptor FbsA promotes adherence of Streptococcus agalactiae to human epithelial cells

The major outer membrane protein rOmpB of spotted fever group rickettsiae functions in the rickettsial adherence to and invasion of Vero cells

In vivo-induced InvA-like autotransporters Ifp and InvC of Yersinia pseudotuberculosis promote interactions with intestinal epithelial cells and contribute to virulence

The BtaF trimeric autotransporter of Brucella suis is involved in attachment to various surfaces, resistance to serum and virulence

Heterologous expression of Bartonella adhesin A in Escherichia coli by exchange of trimeric autotransporter adhesin domains results in enhanced adhesion properties and a pathogenic phenotype

New considerations in infectious disease outbreaks: the threat of genetically modified microbes

Committee on Science, Technology, and Law, Policy and Global Affairs, Board on Health Sciences Policy

Rethinking gain-of-function experiments in the context of the COVID-19 pandemic

Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox

Streptococcal beta-hemolysins: genetics and role in disease pathogenesis

Streptolysin Slike virulence factors: the continuing sagA

Emergence of a bacterial clone with enhanced virulence by acquisition of a phage encoding a secreted phospholipase A2

Streptococcus pyogenes employs strain-dependent mechanisms of C3b inactivation to inhibit phagocytosis and killing of bacteria

Group B streptococcal colonization, molecular characteristics, and epidemiology

A role for C5 and C5a-ase in the acute neutrophil response to group B streptococcal infections

Understanding how leading bacterial pathogens subvert innate immunity to reveal novel therapeutic targets

Gene D. Godbold began working as a government contractor in chemical and biological warfare defense in 2002 after his postdoctoral studies in infectious diseases at the University of Virginia. He has been discerning and annotating sequences of concern (SoCs) for data sets since 2005. His professional enthusiasms include (i) extracting sequence function from the literature in a (semi)automated fashion and (ii) using annotated genome sequences with epidemiological parameters and human immune modeling to anticipate the consequences of "novel" infectious agents. He is currently annotating SARS-CoV-2 proteins and variants for a U.S. CDC-funded project for which Todd Treangen is the principal investigator. He has lived in central Virginia with his family for all but 2 of the last 25 years. He and his wife, Kristen, have eight interesting children, three of whom are still at home. His professional page is https://www.linkedin.com/in/genegodbold/.Anthony D. Kappell is a molecular biologist at Signature Science, LLC, supporting government and commercial clients with his expertise in molecular biology, microbiology, statistical analysis, and bioinformatics. His interests include (i) the structure and function of microbial communities in diverse ecosystems, including natural and engineered water systems, (ii) the anthropological impact of antibiotics and other stressors on microbial communities, and (iii) the harnessing of natural and synthetic microbial communities for human benefit. His doctoral work at the University of Texas at Arlington involved the elucidation of a two- The aim of the IARPA Fun GCAT Program was to detect and define pathogenic and toxic sequences by function, rather than defining sequences solely by taxonomic species of origin. This involved custom curations of sequences using pathogenesis ontologies and expansion of those labels with machine-learning techniques. The resulting software can process short or highly engineered sequences, and it has applications for both biosecurity and fundamental research questions connecting nucleotide sequences to function.